Skip to main content
ImmuneCited

Andrographis 관련 Upper Respiratory Tract Infections

B

Multiple randomized controlled trials and Cochrane-reviewed meta-analyses support andrographis for reducing the severity and duration of upper respiratory symptoms. One of the most evidence-backed herbal supplements for acute respiratory infections.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dandrographis\u0026condition\u003Dupper\u002Drespiratory\u002Dinfections'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

결론

Multiple randomized controlled trials and Cochrane-reviewed meta-analyses support andrographis for reducing the severity and duration of upper respiratory symptoms. One of the most evidence-backed herbal supplements for acute respiratory infections.

Key Study Findings

Randomized Controlled Trial n=331 1.0 weeks Double-blind
Efficacy and safety of AP-Bio®(KalmCold®) in participants with uncomplicated upper respiratory tract viral infection (common …
Dose: 200 mg/day vs: placebo Outcome: URTI symptom severity 효과: None p = 0.034

대상 집단: Participants with uncomplicated URTI

Review
A Comprehensive Review of Andrographis paniculata (Burm. f.) Nees and Its Constituents as Potential Lead …
Dose: None vs: None Outcome: URTI symptom severity 효과: None None

대상 집단: COVID-19/URTI patients

Review
Plant-Based Support of Respiratory Health during Viral Outbreaks.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: None

Other n=179
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, quadruple-blind study.
Dose: 60 mg vs: placebo Outcome: None 효과: None p = 0.0053

대상 집단: None

Meta-Analysis n=1000
Safety of Andrographis paniculata: A systematic review and meta-analysis.
Dose: 95% vs: control Outcome: None 효과: None None

대상 집단: upper respiratory tract infection

Other
In vitro anti-biofilm activity of 14-deoxy-11,12-didehydroandrographolide from Andrographis paniculata against Pseudomonas aeruginosa.
Dose: 6 μg/mL vs: Control group Outcome: None 효과: None None

대상 집단: None

Key Statistics

7

연구

800

참여자

Positive

B

등급

Referenced Papers

Journal of agricultural … 2022 9 인용
Pharmacoepidemiology and drug … 2021 32 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

acute:
400 mg 3x/day for up to 7 days
general:
200 mg standardized extract (30% andrographolides) 2x/day

상한량: No established UL; short-term use (<14 days)

연구에서 사용된 용량

용량 기간 효과 N
200 mg/day 1.0 weeks Positive 331
None -- Positive --
None -- Mixed --
60 mg -- Positive 179
95% -- Neutral 1000
6 μg/mL -- Positive --
None -- Mixed --
18 G 4.0 weeks Mixed --

권장 복용 시간: At first sign of symptoms; with meals

Safety & Side Effects

보고된 부작용

  • Gastrointestinal discomfort (nausea, diarrhea)
  • Headache
  • Fatigue
  • Allergic reactions (rare)
  • Potential anti-fertility effects (high doses in animal studies)

알려진 상호작용

  • Anticoagulant and antiplatelet drugs (may increase bleeding risk)
  • Antihypertensive medications (additive blood pressure lowering)
  • Immunosuppressant medications (may counteract immunosuppression)

일일 최대 섭취 허용량: No established UL; short-term use (<14 days)

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Andrographis help with Upper Respiratory Tract Infections?
Based on 7 studies with 800 participants, there is moderate evidence from clinical studies that Andrographis may support Upper Respiratory Tract Infections management. Our evidence grade is B (Good Evidence).
How much Andrographis should I take for Upper Respiratory Tract Infections?
Studies have used various dosages. A commonly studied range is 400 mg 3x/day for up to 7 days. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Andrographis?
Reported side effects may include Gastrointestinal discomfort (nausea, diarrhea), Headache, Fatigue, Allergic reactions (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Andrographis and Upper Respiratory Tract Infections?
We rate the evidence as Grade B (Good Evidence). This rating is based on 7 peer-reviewed studies with 800 total participants. The overall direction of effect is positive.

Related Evidence

관련 다른 성분: Upper Respiratory Tract Infections

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.